Organigram (TSE:OGI) Hits New 12-Month High – Here’s Why

Organigram Holdings Inc. (TSE:OGIGet Free Report)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as C$2.94 and last traded at C$2.88, with a volume of 1036530 shares changing hands. The stock had previously closed at C$2.61.

Organigram Stock Performance

The firm has a fifty day simple moving average of C$2.34 and a 200 day simple moving average of C$2.20. The company has a current ratio of 3.36, a quick ratio of 2.62 and a debt-to-equity ratio of 3.07. The stock has a market cap of C$384.25 million, a price-to-earnings ratio of 239.17, a PEG ratio of 0.42 and a beta of 2.22.

Insider Transactions at Organigram

In other Organigram news, insider Beena Goldenberg sold 28,242 shares of the business’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total value of C$70,322.58. Following the sale, the insider owned 111,063 shares of the company’s stock, valued at C$276,546.87. The trade was a 20.27% decrease in their position. Also, insider Katrina May Mcfadden sold 11,655 shares of the stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total transaction of C$29,020.95. Following the completion of the transaction, the insider owned 30,326 shares of the company’s stock, valued at approximately C$75,511.74. This represents a 27.76% decrease in their position. Insiders sold 161,555 shares of company stock valued at $385,351 over the last 90 days. Corporate insiders own 31.32% of the company’s stock.

About Organigram

(Get Free Report)

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

See Also

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.